SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Argent Biopharma Executes Global Licence for Cannabis Genetics

Argent Biopharma executed a global licence for its non-core cannabis genetics.

Related stories